Literature DB >> 17114506

Intensity of signal contacting meniscal surface in recurrent tears on MR arthrography compared with that of contrast material.

Arthur A De Smet1, David M Horak, Kirkland W Davis, James J Choi.   

Abstract

OBJECTIVE: Several previous studies reported that the signal contacting the meniscal surface in a recurrent tear on MR arthrography had intensity equal to that of intraarticular contrast material. Because we failed to diagnose recurrent tears using this criterion, we reviewed our knee MR arthrograms in patients who had prior meniscal surgery.
CONCLUSION: On knee MR arthrograms, the signal contacting the surface of a recurrent meniscal tear may be equal to or less than that of adjacent intraarticular gadolinium contrast material.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17114506     DOI: 10.2214/AJR.04.1813

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  4 in total

1.  Incidence of gadolinium or fluid signal within surgically proven glenoid labral tears at MR arthrography.

Authors:  Nicholas C Nacey; Michael G Fox; Christopher J Bertozzi; Jennifer L Pierce; Nicholas Said; David R Diduch
Journal:  Skeletal Radiol       Date:  2019-01-25       Impact factor: 2.199

2.  Accuracy of 3-Tesla MR and MR arthrography in diagnosis of meniscal retear in the post-operative knee.

Authors:  Thomas Magee
Journal:  Skeletal Radiol       Date:  2014-04-22       Impact factor: 2.199

3.  MRI characteristics of torn and untorn post-operative menisci.

Authors:  Richard Kijowski; Humberto Rosas; Adam Williams; Fang Liu
Journal:  Skeletal Radiol       Date:  2017-06-26       Impact factor: 2.199

4.  Retears of postoperative knee meniscus: findings on magnetic resonance imaging (MRI) and magnetic resonance arthrography (MRA) by using low and high field magnets.

Authors:  Paolo Cardello; Carlo Gigli; Alessandra Ricci; Leonardo Chiatti; Nicola Voglino; Enrico Pofi
Journal:  Skeletal Radiol       Date:  2008-10-10       Impact factor: 2.199

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.